Peer-reviewed journal articles (66)
  1. 61. Gurzov, E. N., Bakiri, L., Alfaro, J. M., Wagner, E. F., & Izquierdo, M. (2008). Targeting c-Jun and JunB proteins as potential anticancer cell therapy. Oncogene, 27(5), 641-652. doi:10.1038/sj.onc.1210690
  2. 62. Gurzov, E. N., Ortis, F., Bakiri, L., Wagner, E. F., & Eizirik, D. L. (2008). JunB Inhibits ER Stress and Apoptosis in Pancreatic Beta Cells. PloS one, 3(8), e3030. doi:10.1371/journal.pone.0003030
  3. 63. Gurzov, E. N., Nabha, S. S., Yamamoto, H., Meng, H., Scharovsky, G. O., & Bonfil, D. R. (2007). Paradoxical antiproliferative effect by a murine mammary tumor-derived epithelial cell line. BMC cancer, 7, 184. doi:10.1186/1471-2407-7-184
  4. 64. Gurzov, E. N., & Izquierdo, M. (2006). Cyclin E1 knockdown induces apoptosis in cancer cells. Neurological research, 28(5), 493-499. doi:10.1179/016164106X115143
  5. 65. Pastrana, E., Moreno-Flores, M. T., Gurzov, E. N., Avila, J., Wandosell, F., & Diaz-Nido, J. (2006). Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2. The Journal of neuroscience, 26(20), 5347-5359. doi:10.1523/JNEUROSCI.1111-06.2006
  6. 66. Gurzov, E. N., & Izquierdo, M. (2006). RNA interference against Hec1 inhibits tumor growth in vivo. Gene therapy, 13(1), 1-7. doi:10.1038/sj.gt.3302595
    7.   Papers published in national and international conferences or symposium proceedings (8)
  7. 1. Takiishi, T., Xiao, P., Gurzov, E. N., Bertrand, M., & Cardozo, A. K. (2022). Pancreatic beta cells are resistant to RIPK1 kinase-mediated death. Diabetologia,(vol. 65, p. 211). doi:10.1007/s00125-022-05755-w
  8. 2. Vandenbempt, V., Eski, S. E., Brahma, M. K., Li, A., Demine, S., Xiao, P., Cardozo, A. K., Singh, S. P., Mariño, E., Gysemans, C., & Gurzov, E. N. (2022). Single-cell sequencing reveals preserved pancreatic islet cell identity by administration of metabolite-based diet in autoimmune diabetes. Diabetologia, Vol. 65 , 211. doi:10.1007/s00125-022-05755-w
  9. 3. Brahma, M. K., Xiao, P., Popa, M., Vandenbempt, V., Negueruela Escudero, J., Cardozo, A. K., & Gurzov, E. N. (2021). The Nova1-Bim axis in pancreatic beta-cells does not impact glucose homeostasis in obesity and multiple low-dose streptozotocin-induced diabetes. Diabetologia,(64 (Suppl 1):S1–S380). doi:10.1007/s00125-021-05519-y
  10. 4. Vandenbempt, V., Elvira Jimenez, B., Bauzá-Martinez, J., Negueruela Escudero, J., Ibrahim, H., Winder, M. M., Vekeriotaite, B., Singh, S. P., Rossello, F., Lybaert, P., Otonkoski, T., Gysemans, C., Wu, W., & Gurzov, E. N. (2021). PTPN2 regulates the interferon signalling in pancreatic beta-cells and its expression correlates with therapy outcome in autoimmune diabetes.
  11. 5. Elvira Jimenez, B., Vandenbempt, V., & Gurzov, E. N. (2020). Ptpn2 is a pro-inflammatory cytokine regulator and novel player in the endoplasmic reticulum stress response in beta cells. Diabetologia
  12. 6. Schaschkow, A., Pang, L., Litwak, S. S., Paula, F. M., Eizirik, D. L., Marchetti, P., Gough, D. D., Gurzov, E. N., et al. (2020). Mitochondrial STAT3 contributes to pancreatic beta cell adaptation in obesity. Diabetologia
    13. << Previous 1 2 3 4 5 6 7 8 9 Next >>